- A Seattle Times article about the sudden death of Boeing whistle-blower Josh Dean prompted speculation in-channel about possible bioweapon use or deliberate poisoning and subsequent misdiagnosis.  
- Bryan Bishop pushed a commit to the DIYH+ wiki adding an explicit warning about research risks and the potential for harmful mutations on the “genetic modifications” page (http://diyhpl.us/diyhpluswiki/genetic-modifications/).  
- Discussion of Rejuvenate Bio, a startup spun out of George Church’s lab, which is already delivering AAV-based triple-gene therapy (FGF21, sTGFβR2, αKlotho) to pet dogs as a longevity intervention.  
- Reference to a 2020 Harvard OTD announcement (https://otd.harvard.edu/news/rejuvenate-bio-launches-to-help-dogs-live-longer-healthier-lives/) summarizing the mouse data that underpins the canine program.  
- Brief mention that Rejuvenate Bio is also developing a separate Yamanaka-factor gene therapy, distinguishing it from the FGF21/sTGFβR2/αKlotho approach.